Please login to the form below

Not currently logged in
Email:
Password:

Clinigen appoints Shaun Chilton as COO of services division

Former KnowledgePoint360 Group president and MD will head both Keats Healthcare and Clinigen GAP

Clinigen, the UK-based specialty pharmaceutical and pharma services provider, has appointed Shaun Chilton to the newly-created role of chief operating officer of the group's services division.

Chilton joins from healthcare information supplier KnowledgePoint360 Group, where he was both president and managing director.

In his new role he will head both Clinigen's clinical trial supply business Keats Healthcare and Clinigen GAP, a specialist provider of early- and late-lifecycle prescription drugs, streamlining the two businesses.

Keats Healthcare, which was acquired by Clinigen in 2010, is currently being rebranded as Clinigen CTS.

Commenting on the appointment, Chilton said: “Keats Healthcare and Clinigen GAP are already successful businesses providing standalone services, but they are highly complementary and synergies between the two companies make their combination into a services division compelling.”

He joins the company from KnowledgePoint360 Group, a supplier of healthcare information, and prior to that held positions in sales and marketing at both Pfizer and Sanofi.

Peter George, CEO of Clinigen, said: “Shaun has a strong track record of building and leading high-performance sales and operational teams; driving commercial growth from international businesses; developing highly effective strategies, including major restructurings; and executing new strategies to deliver business goals, improve profitability and meet challenging targets.”

23rd January 2012

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Solaris Health

The beauty of detail: an effective, compelling medical communications campaign requires each component to be carefully planned, expertly crafted and...

Latest intelligence

AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...

Infographics